Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |